India s Sensex Declines for Third Day as Pandemic Worry Lingers - Article bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
ABCD Technologies onboards new partners to boost pharma supply chain
ABCD Technologies onboards new partners to boost pharma supply chain
03 May 2021 | News
Source credit: Shutterstock
ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has announced that nine new partners have joined the initiative aimed at developing a world-class pharmaceutical supply chain & distribution IT ecosystem in India.
The new partners include Glenmark Pharmaceuticals Ltd, Emcure Pharmaceuticals Ltd, USV Private Ltd, Micro Labs Ltd, Alembic Pharmaceuticals Ltd, Cadila Pharmaceuticals Ltd, Ajanta Pharma Ltd, Ipca Laboratories Ltd and Intas Pharmaceuticals Ltd.
With the addition of new partners, ABCD Technologies LLP now has 17 partners. The companies who had joined earlier included Alkem Laboratories Ltd, Zydus HealthCare Ltd, Cipla Ltd, Dr Reddy’s Laboratories Ltd, Lupin Ltd, Mankind Pharma Ltd, Sun Pharma Distributors Ltd and Torrent Pharmaceuticals Ltd. The partnership is aimed at
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020
ACCESSWIRE
Preliminary Results for the Year Ended 31 December 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020.
Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its R&D pipeline through technology collaborations with third party pharmaceutical companies, the initiation of new internal programmes and adding new indications to MTX110.
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020
Preliminary Results for the Year Ended 31 December 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020.
Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its R&D pipeline through technology collaborations with third party pharmaceutical companies, the initiation of new internal programmes and adding new indications to MTX110.
The Company s realigned strategy is to advance its development programmes to proof of concept stage before seeking licensee partners to fund further development, manufacturing scale-up and commercialisation.